Laparoscopic Versus Open Complete Mesocolic Excision With Central Vascular Ligation in Right Colon Cancer
NCT ID: NCT03826446
Last Updated: 2019-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2016-01-13
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Open Versus Laparoscopic Right Hemicolectomy for Right Colon Cancer
NCT04434508
Combined Medial and Caudal Approach for Right Hemicolectomy
NCT05128708
Laparoscopic Colectomies In Management of Colonic Cancers
NCT04972994
Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt
NCT05421702
The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment
NCT04079946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The right colon has a large caliber, a thin wall, and its contents are liquid; thus, obstruction is a late event. Bleeding is usually occult. Fatigue and weakness caused by severe anemia may be the only complaints. Tumors sometimes grow large enough to be palpable through the abdominal wall before other symptoms appear.
Curative treatment for right colon cancer includes resection of the tumor-bearing bowel segment. There are standard types of operations, depending on the location of the tumor. The types of standard resections are based on the knowledge of lymphatic drainage and lymph node anatomy.
Right sided hemicolectomy is the standard type of operation for cancers in the caecum, the ascending colon. In 2009, Hohenberger, a German scholar, proposed the term of complete mesocolic excision (CME), whose basic theory is mainly composed of two concepts in fetal anatomy and surgical oncology: sharp dissection of the mesocolic plane and the parietal plane. CME helps to keep the colonic mesentery intact, clarify the dissected area from central lymph nodes, emphasize the importance of transecting colon-feeding blood at the root, and increase the range of longitudinal enterotomy. Thus, CME provides a standardization of surgeries for colon cancer.
Traditionally, approach to right colon cancer is through open exploration but this approach has more blood loss, prolonged postoperative hospital stay, sever postoperative pain and delayed recovery..
Laparoscopic right colectomy (LRC) for colon cancer became a well-established technique in the surgical armamentarium of colorectal operations. It has well proved advantages: reduction in postoperative pain, time to return of bowel function, and length of hospital stay.
The purpose of the present study was to compare between laparoscopic and open complete mesocolic excision with central vascular ligation in right colon cancer as regards technical feasibility, advantages and disadvantages of both procedures.
This was prospective randomized study and was carried out on 60 patients diagnosed as operable right sided colon cancer and the patients will be divided into two groups:
Group I: Open right hemicolectomy with complete mesocolic excision with central vascular ligation.
Group II: Laparoscopic right hemicolectomy with complete mesocolic excision with central vascular ligation.
All patients were subjected to preoperative assessment in the form of:
* Full history.
* Clinical evaluation and body weight.
* Laboratory investigation (Complete blood picture, liver function tests, blood sugar, blood urea, serum creatinine, prothrombin time, serum albumin and tumour markers(.
* Imaging (chest X-ray, US abdomen, CT abdomen and pelvis).
* Histopathology diagnosis (endoscopic biopsy, tissue diagnosis).
Operative technique
In patients of group I:
* A standard mechanical bowel preparation will be performed 24 hours before operation.
* The patient will be placed in the supine position and the operation will be carried out in a standard manner.
* A midline incision of about 15 to 20 cm will be made.
* The right-sided colon will be mobilized before mesenteric division and the same vessels will be dissected frequently.
* Ileotransverse end-to-end hand anastomosis is operated and the mesenteric defect will be closed.
In patients of group II:
* A standard mechanical bowel preparation will be performed 24 hours before the operation.
* A high-definition laparoscope will be used.
* Under general anaesthesia the operation is carried out in standard manner, with the patient in a modified lithotomy position.
* After achieving pneumoperitoneum (12 mm Hg), a 12-mm trocar will be placed through an incision just above the umbilicus, and a 30-degree laparoscope will be inserted through the 12-mm trocar. The second 10-mm trocar will be inserted at the upper left quadrant of the abdomen for the major acting port. The third 5-mm trocar will be inserted at the lower left quadrant for the second major active port. The fourth and fifth 5-mm trocars will be inserted at the upper right and lower right quadrants.
* According to laparoscopic procedure, the position, composition, and spatial relationships of the surgery planes needed for laparoscopic complete mesocolic excision for right sided colic cancer cases are identified.
Intraoperatively, all patients will be assessed for:
* Time of the procedure.
* Amount of blood loss.
Postoperative follow up:
Patients will be followed up by the standardized follow up protocol. They will be examined by the outpatient setting after:
* 2 weeks (post-operative) for: wound infection, leakage, pathological outcome (The tumor node metastasis (TNM) stage, histologic grade of differentiation, number of harvested lymph nodes, lymphovascular invasion, estimation of resection margins).
* Every 3 months for 1-2 years by: history taking, physical examination, carcinoembryonic antigen measurement,
* Every 6 months for 1-2 years by: chest, abdomen-pelvic computed tomography for detection of local or systemic recurrence.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open Surgery
Patients diagnosed as operable right sided colon cancer were enrolled in this study and did open complete mesocolic excision procedures
Surgery
laparoscopic and open complete mesocolic excision with central vascular ligation in right colon cancer.
Laparoscopic Surgery
Patients diagnosed as operable right sided colon cancer were enrolled in this study and did laparoscopic complete mesocolic excision procedures
Surgery
laparoscopic and open complete mesocolic excision with central vascular ligation in right colon cancer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgery
laparoscopic and open complete mesocolic excision with central vascular ligation in right colon cancer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. No permeation of surrounding fat planes.
2. No encasement of major vascular structures.
3. No extensive local spread.
4. No distant metastases or peritoneal infiltration were included in this study.
Exclusion Criteria
50 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Menoufia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karim Mohamed Shady
kshady- Principal investigstor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine
ShebinElkom, Menoufia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Faculty of medicine-MenoufiaU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.